news Apitope raises €12 million in Series B funding 29 September 2015 | By Victoria White The funds will enable Apitope to progress the clinical development of its innovative pipeline which includes therapies for Factor VIII intolerance in Haemophilia A patients...
news FDA Grants Orphan Status for ATX-F8-117 for the treatment of haemophilia A patients in the US 9 June 2015 | By Victoria White Apitope’s product candidate ATX-F8-117 has been granted Orphan Drug Status by the FDA for the treatment of patients with haemophilia A in the US...